CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 


Moderna Inc 's Net Profit Margin by quarter

Trends, Rankings, Statistics



MRNA Net Profit Margin (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Revenue Change 3046.73 % 6462.07 % 22989.76 % 431893.13 % 309527.45 %
Seq. Revenue Change 14.12 % 124.78 % 239.38 % 261.44 % 137.99 %
Revenue In Millions $4,969.00 $4,354.00 $1,937.00 $570.75 $157.91
Net Profit Margin 67.08 % 63.85 % 63.04 % - -
Net Profit Margin Total Ranking # 203 # 183 # 158 # #
Net Income In Millions $3,333.00 $2,780.00 $1,221.00 $-272.49 $-233.64
Y / Y Net Income Change - - - - -
Seq. Net Income Change 19.89 % 127.68 % - - -


Commenting Third Quarter 2021 Net Profit Margin
Moderna Inc Net Income grew by 19.89 % in III. Quarter sequntially to 3,333 millions, while Revenue increased by 14.12 %, this led to improvement in Company's Net Profit Margin to 67.08 %, Net Profit Margin remained below Moderna Inc average.

Observing third quarter 2021 results within Biotechnology & Pharmaceuticals industry 8 other companies have achieved higher Net Profit Margin. While Net Profit Margin overall ranking has deteriorated compare to previous quarter from 183 to 203.
Net Margin Formula
MRNA's Net Profit Margin third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 27
Overall # 203

Net Profit Margin Statistics
High Average Low
961.25 % 324.75 % 63.04 %
(Sep 30 2015)   (Mar 31 2021)




Other Net Profit Margin Profitability Ratios
MRNA's Cumulative Net Profit Margin
Biotechnology & Pharmaceuticals Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
MRNA's Net Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for MRNA's Competitors
Net Profit Margin Profit Margin for Moderna Inc 's Suppliers
Net Profit Margin Profit Margin for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Net Income Growth
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons


Companies with similar Net Profit Margin in the quarter ending Sep 30 2021, within Biotechnology & Pharmaceuticals Industry Net Profit MarginSep 30 2021 MRQ Net IncomeSep 30 2021 MRQ Revenue
American Bio Medica Corporation  107.98 %$ 0.663 $ 0.614 
Vir Biotechnology Inc   106.57 %$ 110.428 $ 103.616 
Agenus Inc  70.08 %$ 177.277 $ 252.954 
Moderna Inc   67.08 %$ 3,333.000 $ 4,969.000 
Iteos Therapeutics Inc   66.79 %$ 69.642 $ 104.271 
Fulgent Genetics Inc   53.64 %$ 122.224 $ 227.868 
Iterum Therapeutics Plc  38.24 %$ 3.741 $ 9.783 
Royalty Pharma Plc  37.86 %$ 221.796 $ 585.773 
Gilead Sciences Inc   34.85 %$ 2,586.000 $ 7,421.000 
Bio techne Corp  26.77 %$ 68.981 $ 257.719 
Abbvie Inc   22.17 %$ 3,180.000 $ 14,342.000 
Axon Enterprise inc   20.92 %$ 48.524 $ 231.989 
Repligen Corp  18.80 %$ 33.498 $ 178.216 
Hydrofarm Holdings Group Inc   13.94 %$ 17.265 $ 123.822 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GLD's Profile

Stock Price

GLD's Financials

Business Description

Fundamentals

Charts & Quotes

GLD's News

Suppliers

GLD's Competitors

Customers & Markets

Economic Indicators

GLD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071